Vimarsana
Biggest News Aggregation in the World

Page 23 - Manufacturing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manufacturing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manufacturing Program Today - Breaking & Trending Today

Ascentage Pharma Announces 2022 Interim Results - Vimarsana News

Ascentage Pharma Announces 2022 Interim Results

SUZHOU, China and ROCKVILLE, Md. , Aug. 26, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis

Ascentage Pharma Announces 2022 Interim Results - Vimarsana News

Ascentage Pharma Announces 2022 Interim Results

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

North Alabama schools connecting students to career training - Vimarsana News

North Alabama schools connecting students to career training

The four pilot programs are: Guntersville High School, Hartselle High School, Limestone County Career Technical Center, and Madison County Career Technical Center.

Senate Passes Chips-Plus Package, House Passage Imminent - Government Contracts, Procurement & PPP - Vimarsana News

Senate Passes Chips-Plus Package, House Passage Imminent - Government Contracts, Procurement & PPP

In a bipartisan vote of 64-33, the Senate passed legislation earlier today to fund domestic semiconductor manufacturing and boost federal scientific research and development.

Source: mondaq.com
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML - Vimarsana News

Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...